Suppr超能文献

洛哌丁胺(易蒙停)——临床试验。

Loperamide (imodium)--clinical trial.

作者信息

Dzieniszewski J, Ciok J, Jarosz M

机构信息

Department of Metabolic Diseases, Institute of Food and Nutrition, Warsaw, Poland.

出版信息

Ther Hung. 1990;38(2):60-3.

PMID:2198677
Abstract
  1. Imodium (loperamide) produced by Chemical Works of Gedeon Richter, Budapest, is a useful preparation for the symptomatic treatment of both acute and chronic diarrhoea of various etiologies. 2. In chronic diarrhoea cases the best results were obtained in the treatment of functional disorders of the guts. 3. Side effects occurred only in few patients and with low intensity, the treatment had to be interrupted in none of the cases.
摘要
  1. 由布达佩斯吉东·里奇特化学工厂生产的易蒙停(洛哌丁胺)是一种用于对症治疗各种病因引起的急慢性腹泻的有效制剂。2. 在慢性腹泻病例中,对肠道功能紊乱的治疗取得了最佳效果。3. 副作用仅在少数患者中出现,且强度较低,无一例需要中断治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验